Search | Contact Us  





Flyer™ RX Norway Registry Summary
Results at 180 Days
Device Success by QCA 99.7% (304/305)
Procedure Success by QCA 99.5% (199/200)
Subacute Thrombosis 0.5% (1/200)
MACE
  Death
  MI
  TLR
7.0% (14/200)
  1.0% (2/200)
  1.0% (2/200)
  5.0% (10/200)
MACE w/TVF
  TVR (non-TLR)
  TVF w/o intervention
9.0% (18/200)
  1.0% (2/200)
  1.0% (2/200)
Emergent Cases 56.0% (112/200)

 

 

 

 

 

*Not available in the US.

Atrium’s FLYER™ RX Coronary Stent System is an engineering marvel. A perfect blend of Finite Element Analysis (FEA) design mated with Atrium’s exclusive HyperLite™ PTCA balloon technology. Flyer is everything you’d consider in selecting a low profile rapid exchange coronary stent platform. Advanced engineering has created one of the best performing side branch access geometries, packaged onto an incredibly flexible, low profile HyperLite LX PTCA catheter. Thanks to our revolutionary ARC™ strut technology, Flyer’s ring elements expand uniformly for enhanced tissue prolapse protection. Together with our Zero Flex Interference technology, Flyer maintains its smooth, low profile crimp shape during extreme flexing and torquing. Flyer not only gets you there fast, but with elegant precision and uniform expansion every time!


Flyer Registry Study Complete Results
Flyer patient registry evaulating performance and outcomes of Atrium Flyer Coronary Stent System.




Single Center Consecutive Registry Of The New Atrium Flyer Coronary Stent System.
Dr. Kjellevand's presentation demonstrating economic benefit of a quality bare metal stent (Flyer). Presented at 19th Annual Interventional Cardiology 2004



 
*Not available in the US.
Atrium ® Copyright 2008 Atrium Medical Corporation. All rights reserved. | Terms and Conditions | Privacy Policy